2018
DOI: 10.1177/1129729818779702
|View full text |Cite
|
Sign up to set email alerts
|

Experimental study on the hemostatic effect of cyanoacrylate intended for catheter securement

Abstract: This study indicates that cyanoacrylate demonstrates a potent mechanical hemostatic effect and cyanoacrylate in the presence of anticoagulated whole blood has an activated clotting time that is 12 times quicker than thromboplastin. The cyanoacrylate was found to be significantly equivalent to two known hemostatic agents, in vivo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 19 publications
0
10
0
Order By: Relevance
“…This indicates that CAG is a promising application at reducing bleeding after VAD insertion, but haemostasis must be in place prior to application. These properties have been observed in vitro and in vivo in pigs 18 at 3, 6, 9 and 12 min after treatment. It has also been seen with different VADs: PICCs, 7 , 14 , 30 CICCs 11 and arterial catheters.…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…This indicates that CAG is a promising application at reducing bleeding after VAD insertion, but haemostasis must be in place prior to application. These properties have been observed in vitro and in vivo in pigs 18 at 3, 6, 9 and 12 min after treatment. It has also been seen with different VADs: PICCs, 7 , 14 , 30 CICCs 11 and arterial catheters.…”
Section: Discussionmentioning
confidence: 73%
“… 13 Their safe use has been verified in adults, 14 paediatric patients 15 and neonatal patients. 16 , 17 CAG has also been shown to have a strong haemostatic effect in the presence of blood, 18 and its long-term use does not damage polyurethane catheters. 19 On the negative side, it has been suggested that its use might not be suitable for patients with sensitive skin or cutaneous diseases, and healthcare personnel training has been recommended as cases have been reported of tissue damage due to incorrect removal of the product.…”
Section: Introductionmentioning
confidence: 99%
“…Although cyanoacrylates have excellent mechanical hemostasis, they cannot promote blood coagulation 43 . SNPs can accelerate blood coagulation by promoting the aggregation of platelets and red blood cells 25,26 .…”
Section: Resultsmentioning
confidence: 99%
“…Although cyanoacrylates have excellent mechanical hemostasis, they cannot promote blood coagulation. 43 SNPs can accelerate blood coagulation by promoting the aggregation of platelets and red blood cells. 25,26 Recalcification clotting measurements were carried out to assess the coagulation efficiency of the samples.…”
Section: Coagulation Propertiesmentioning
confidence: 99%
“…The third study reviewed measured the effect of hemostasis of one CSCA, SecurePortIV, through in vitro and in vivo testing methods 42. The data from the in vitro tests demonstrated that SecurePortIV achieved consistent inhibition of blood flow and rapidly modified activated clotting times.…”
Section: Discussionmentioning
confidence: 99%